findmyKOL
Clinical trialNCT02267642CompletedPhase 2Interventional

A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis

SponsorAbGenomics B.V Taiwan BranchEnrollment20Psoriatic Arthritis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Uc San Diego

    La Jolla, California, United States

  • Stanford University

    Palo Alto, California, United States

  • Sarasota Arthritis Research Center

    Sarasota, Florida, United States

  • Northwestern University

    Chicago, Illinois, United States

  • Justus J. Fiechtner, Md, Pc

    Lansing, Michigan, United States

  • Metroplex Clinical Research Center, Llc

    Dallas, Texas, United States

  • Seattle Rheumatology Associates/swedish Clinical Research

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2015
Primary completion
31 Oct 2015
Completion
31 Jan 2016
Last update posted
24 Jan 2017
Registered enrollment
20
Registry id
NCT02267642

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.